Pharmaceuticals

Sort by Latest
The Second Draft Patent Examination Guidelines on Patent Linkage Invalidation, PTE and PTA
TTThe second draft amendment to the Patent Examination Guidelines (the “
November 3, 2022
4 min read
The Pharmaceutical Intellectual Property and Competition Law Review
The Pharmaceutical Intellectual Property and Competition Law Review provides a practical overview...
September 16, 2022
1 min read
China’s First Supreme Court Patent Linkage Decision
On 5 August 2022, the Chinese Supreme Court (the “SPC”) handed down the second instance judgment on...
September 7, 2022
11 min read
Spanish Competition Authority analyses distribution of medicines in Spain
On June 22, 2022, the Spanish Competition Authority (“CNMC”) published a study about the wholesale...
July 18, 2022
6 min read
To opt-out or not? The UPC will change the rules of the game in the European patent field possibly as soon as next fall
Early this year it became clear that the long-pending reform of the European patent system is finally...
June 1, 2022
7 min read
New Draft Implementing Regulations propose key changes for pharmaceuticals in China
On 9 May 2022, the National Medical Products Administration (the “NMPA”) published the Implementing Regulations...
May 19, 2022
5 min read
The UPC Committees rule!
Start of the Provisional Application Phase and first committee meetings The Provisional...
April 7, 2022
12 min read
The Return of Biosimilar Substitution in France
Every year the Social Security Financing Law for 2022 (LFSS 2022) introduces several measures resulting...
March 28, 2022
3 min read
International Comparative Legal Guide to Digital Health 2022
Our Life Sciences IP, Regulatory and Data Protection experts Sally Shorthose, Toby Bond, Emma Drake and...
March 17, 2022
1 min read
Renewal of early access and compassionate use frameworks in France
On 1 July 2021, the early access and compassionate use reform entered into force. A medical treatment...
November 10, 2021
6 min read